InnovHeart fetches Series B

Milan, Italy and Newton, Massachusetts-based InnovHeart, a developer of novel transcatheter mitral valve replacement systems for the treatment of mitral valve disease, has raised 20 million euros in Series B financing.

To view this content, you need to sign in.

You should only be asked to sign in once. Not the case? Click here

Register now to access this content and more for free.

Share this